These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension. Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494 [TBL] [Abstract][Full Text] [Related]
25. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells. Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884 [TBL] [Abstract][Full Text] [Related]
26. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Hagen M; Fagan K; Steudel W; Carr M; Lane K; Rodman DM; West J Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1473-9. PubMed ID: 17322283 [TBL] [Abstract][Full Text] [Related]
27. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension. Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577 [TBL] [Abstract][Full Text] [Related]
28. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension. Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442 [TBL] [Abstract][Full Text] [Related]
29. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8. Drake KM; Zygmunt D; Mavrakis L; Harbor P; Wang L; Comhair SA; Erzurum SC; Aldred MA Am J Respir Crit Care Med; 2011 Dec; 184(12):1400-8. PubMed ID: 21920918 [TBL] [Abstract][Full Text] [Related]
30. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395 [TBL] [Abstract][Full Text] [Related]
31. Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension. Wang H; Li W; Zhang W; Sun K; Song X; Gao S; Zhang C; Hui R; Hu H Eur J Hum Genet; 2009 Aug; 17(8):1063-9. PubMed ID: 19223935 [TBL] [Abstract][Full Text] [Related]
32. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function. Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187 [TBL] [Abstract][Full Text] [Related]
33. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357 [TBL] [Abstract][Full Text] [Related]
35. BMP pathway regulation of and by macrophages. Talati M; West J; Zaynagetdinov R; Hong CC; Han W; Blackwell T; Robinson L; Blackwell TS; Lane K PLoS One; 2014; 9(4):e94119. PubMed ID: 24713633 [TBL] [Abstract][Full Text] [Related]
36. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Willers ED; Newman JH; Loyd JE; Robbins IM; Wheeler LA; Prince MA; Stanton KC; Cogan JA; Runo JR; Byrne D; Humbert M; Simonneau G; Sztrymf B; Morse JA; Knowles JA; Roberts KE; McElroy JJ; Barst RJ; Phillips JA Am J Respir Crit Care Med; 2006 Apr; 173(7):798-802. PubMed ID: 16339917 [TBL] [Abstract][Full Text] [Related]
37. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension. Wong WK; Knowles JA; Morse JH Am J Respir Cell Mol Biol; 2005 Nov; 33(5):438-46. PubMed ID: 16002577 [TBL] [Abstract][Full Text] [Related]
38. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Orriols M; Gomez-Puerto MC; Ten Dijke P Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104 [TBL] [Abstract][Full Text] [Related]
39. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Cheng G; Wang X; Li Y; He L Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784 [TBL] [Abstract][Full Text] [Related]
40. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation. Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]